Premium
Tumor‐related epilepsy and epilepsy surgery
Author(s) -
Lhatoo Samden D.,
Moghimi Narges,
Schuele Stephan
Publication year - 2013
Publication title -
epilepsia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.687
H-Index - 191
eISSN - 1528-1167
pISSN - 0013-9580
DOI - 10.1111/epi.12435
Subject(s) - epilepsy , epilepsy surgery , medicine , pace , intractable epilepsy , epidemiology , intensive care medicine , clinical practice , neuroscience , psychiatry , psychology , pathology , family medicine , geodesy , geography
Summary Tumor‐related epilepsy ( TRE ) is a major etiologic category of epilepsy. TRE is heterogeneous, and the epidemiology, pathology, pathophysiology, clinical features, treatment, and outcomes vary accordingly. In addition, treatment imperatives vary between almost purely epilepsy considerations and those that are primarily oncologic. Often, there is no clear separation of imperatives, and there is a relatively scant evidence base that underpins management decisions in such cases. Given a diverse molecular as well as clinical landscape and the rapid pace with which new knowledge accrues, there are relatively few recent literature resources on TRE that provide neurologists, neurosurgeons, epileptologists, and oncologists with an up‐to‐date, state‐of‐the‐art review of the field in all of its important aspects. The proceedings of the S ixth I nternational E pilepsy C olloquium in C leveland in O hio, U . S . A ., in M ay 2013 on Tumoral Epilepsy and Epilepsy Surgery address, at least in part, several TRE aspects crucial to modern epilepsy and oncology practice.